GLP-1s and Risk of Age-Related Ocular Disease Podcast Por arte de portada

GLP-1s and Risk of Age-Related Ocular Disease

GLP-1s and Risk of Age-Related Ocular Disease

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

 How do GLP-1 drugs influence age-related ocular diseases such as macular degeneration and glaucoma? Moderator Lediana Goduni, MD, is joined by Alexis Warren, MD, and Joshua Uhr, MD, to examine a retrospective study published in Ophthalmology using TriNetX data to compare 5-year ocular outcomes across medication cohorts. Do these data suggest a protective benefit for GLP-1s—and does it matter for clinical practice? Tune in for their take on what’s promising, what’s premature, and what’s next.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones